[1] |
Russell SE, Stefanska AM, Kubica M, et al. Toll IL⁃1R8/single Ig IL⁃1⁃related receptor regulates psoriasiform inflammation through direct inhibition of innate IL⁃17A by γδ T cells[J]. J Immunol, 2013,191(6):3337⁃3346. doi: 10.4049/jimmunol.1300828.
|
[2] |
Jameson JM. γδ T cells: a disappearing act with a big reveal[J].J Exp Med, 2018,215(12):2962⁃2963. doi: 10.1084/jem.2018 1960.
|
[3] |
Gray EE, Ramírez⁃Valle F, Xu Y, et al. Deficiency in IL⁃17⁃committed Vγ4(+) γδ T cells in a spontaneous Sox13⁃mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis[J]. Nat Immunol, 2013,14(6):584⁃592. doi: 10.1038/ni.2585.
|
[4] |
Nakamizo S, Egawa G, Tomura M, et al. Dermal Vγ4(+) γδ T cells possess a migratory potency to the draining lymph nodes and modulate CD8(+) T⁃cell activity through TNF⁃α production[J]. J Invest Dermatol, 2015,135(4):1007⁃1015. doi: 10.1038/jid.2014.516.
|
[5] |
Oukka M, Bettelli E. Regulation of lymphocyte trafficking in central nervous system autoimmunity[J]. Curr Opin Immunol, 2018,55:38⁃43. doi: 10.1016/j.coi.2018.09.008.
|
[6] |
Wu B, Zhang S, Guo Z, et al. RAS P21 protein activator 3 (RASA3) specifically promotes pathogenic T helper 17 cell generation by repressing T⁃helper⁃2⁃cell⁃biased programs[J]. Immunity, 2018,49(5):886⁃898.e5. doi: 10.1016/j.immuni.2018. 09.004.
|
[7] |
Brinkmann V. FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system[J]. Br J Pharmacol, 2009,158(5):1173⁃1182. doi: 10.1111/j. 1476⁃5381.2009.00451.x.
|
[8] |
Ramírez⁃Valle F, Gray EE, Cyster JG. Inflammation induces dermal Vγ4+ γδT17 memory⁃like cells that travel to distant skin and accelerate secondary IL⁃17⁃driven responses[J]. Proc Natl Acad Sci U S A, 2015,112(26):8046⁃8051. doi: 10.1073/pnas. 1508990112.
|
[9] |
Brembilla NC, Senra L, Boehncke WH. The IL⁃17 family of cytokines in psoriasis: IL⁃17A and beyond[J]. Front Immunol, 2018,9:1682. doi: 10.3389/fimmu.2018.01682.
|
[10] |
Zeichner JA, Armstrong A. The role of IL⁃17 in the pathogenesis and treatment of psoriasis[J]. J Clin Aesthet Dermatol, 2016,9(6 Suppl 1):S3⁃3S6.
|
[11] |
Mendoza A, Fang V, Chen C, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells[J]. Nature, 2017,546(7656):158⁃161. doi: 10.1038/nature 22352.
|
[12] |
Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL⁃17⁃producing γδ T cells in skin inflammation[J]. Immunity, 2011,35(4):596⁃610. doi: 10.1016/j.immuni.2011.08.001.
|
[13] |
Rosen H, Gonzalez⁃Cabrera PJ, Sanna MG, et al. Sphingosine 1⁃phosphate receptor signaling[J]. Annu Rev Biochem, 2009,78:743⁃768. doi: 10.1146/annurev.biochem.78.072407.103733.
|
[14] |
Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1[J]. Nature, 2004,427(6972):355⁃360. doi: 10.1038/nature02284.
|
[15] |
Torkildsen Ø, Myhr KM, Bø L. Disease⁃modifying treatments for multiple sclerosis ⁃ a review of approved medications[J]. Eur J Neurol, 2016,23 (Suppl 1):18⁃27. doi: 10.1111/ene.12883.
|
[16] |
Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin⁃17⁃producing gammadeltaT cells in the delayed phase of ischemic brain injury[J]. Nat Med, 2009,15(8):946⁃950. doi: 10.1038/nm.1999.
|